Which of the following requirements must be fulfilled before a gene therapy procedure will be approved? 1)The gene must be cloned and well characterized 2)The risks of gene therapy to the patient must have been carefully evaluated and shown to be minimum 3)The disease must not be treatable by other strategies
The genetic cause of Huntington's disease can best be described as a/an:
A) Increased trinucleotide repeat in the huntingtin gene B) Increased trinuclotide repeat in the fibrosin gene C) Decreased trinucleotide repeat in the huntingtin gene D) Decreased trinucleotide repeat in the fibrosin gene E) None of these